Angiogenesis as a potential biomarker in prostate cancer chemoprevention trials
- PMID: 11295614
- DOI: 10.1016/s0090-4295(00)00961-4
Angiogenesis as a potential biomarker in prostate cancer chemoprevention trials
Abstract
Prostate cancer is a multistep process in which progression rather than initiation may be the rate-limiting step. A strong possibility is that prostatic intraepithelial neoplasia lesions that switch to angiogenic phenotype eventually progress to cancer. However, it is a challenging task to quantitate angiogenesis in preneoplastic lesions. A promising approach to measuring angiogenesis involves real-time TaqMan polymerase chain reaction to quantitate mRNAs encoding a panel of angiogenesis markers. This highly sensitive molecular technique has potential for quantitating angiogenesis in clinical settings and can be used as a high-throughput screening procedure in prostate cancer clinical trials.
Similar articles
-
Vascular endothelial growth factor expression and capillary architecture in high-grade PIN and prostate cancer in untreated and androgen-ablated patients.Prostate. 2000 Sep 15;45(1):72-9. doi: 10.1002/1097-0045(20000915)45:1<72::aid-pros9>3.0.co;2-u. Prostate. 2000. PMID: 10960845
-
A potential autocrine role for vascular endothelial growth factor in prostate cancer.Cancer Res. 2002 Feb 1;62(3):854-9. Cancer Res. 2002. PMID: 11830543
-
Angiogenesis and prostate cancer: identification of a molecular progression switch.Cancer Res. 2001 Mar 15;61(6):2736-43. Cancer Res. 2001. PMID: 11289156
-
Angiogenesis and prostate cancer tumor growth.J Cell Biochem. 2004 Jan 1;91(1):125-50. doi: 10.1002/jcb.10772. J Cell Biochem. 2004. PMID: 14689586 Review.
-
Role of angiogenesis in the progression and treatment of prostate cancer.Cancer Invest. 2001;19(2):181-91. doi: 10.1081/cnv-100000152. Cancer Invest. 2001. PMID: 11296622 Review. No abstract available.
Cited by
-
Role of androgen and vitamin D receptors in endothelial cells from benign and malignant human prostate.Am J Physiol Endocrinol Metab. 2013 Jun 1;304(11):E1131-9. doi: 10.1152/ajpendo.00602.2012. Epub 2013 Apr 2. Am J Physiol Endocrinol Metab. 2013. PMID: 23548616 Free PMC article. Review.
-
Mechanism of growth inhibition of prostate cancer xenografts by valproic acid.J Biomed Biotechnol. 2012;2012:180363. doi: 10.1155/2012/180363. Epub 2012 Oct 2. J Biomed Biotechnol. 2012. PMID: 23093837 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical